PDF(Sci-hub)
Abstract：
Facial aesthetic treatment with injectable neuromodulators and hyaluronic acid fillers is well established, with favourable safety profiles and consistent outcomes. As with any medical treatment, adverse events and complications may occur. Adverse events associated with these products are typically transient and mild to moderate in severity. Serious adverse events, such as infection and intravascular occlusion, are rare. Proper patient selection, consent and counselling, preparation and impeccable injection technique are important risk reduction strategies. Both clinicians and patients must be alert to the signs and symptoms of complications so that appropriate treatment can be started promptly. In this article, the authors review the current literature and provide their consensus recommendations for minimising adverse outcomes when treating patients with botulinum toxin or hyaluronic acid fillers.
摘要：
使用可注射神经调质和透明质酸填充剂进行面部美容治疗已得到完善，具有良好的安全性和一致的结果。和任何医疗一样，可能发生不良事件和并发症。与这些产品相关的不良事件通常是短暂的，严重程度为轻度至中度。严重不良事件,如感染和血管内闭塞，是罕见的。正确选择病人,同意和咨询，准备和无可挑剔的注射技术是重要的降低风险的策略。临床医生和患者都必须警惕并发症的体征和症状，以便及时开始适当的治疗。在这篇文章中,作者回顾了目前的文献,并提供了他们在使用肉毒杆菌毒素或透明质酸填充剂治疗患者时将不良结局降至最低的共识建议.
